CT引导下肺活检:低剂量与标准剂量方案的随机对照试验
这项单中心、单盲、前瞻性随机对照试验将280例患者随机分入低剂量或标准剂量CT引导下肺活检组,最终271例接受干预。两组技术成功率均为100%,诊断准确率无显著差异,低剂量组有效剂量显著降低(0.5 mSv vs 5.1 mSv)。
要点
- 低剂量CT引导下肺活检的诊断准确率与标准剂量方案相当(94.6% vs 92.4%)。
- 低剂量组有效剂量较标准剂量组降低约90%(0.5 mSv vs 5.1 mSv)。
- 病灶较大和操作相关气胸是诊断失败的独立预测因素。
核心结论
- 低剂量CT引导下肺活检可获得与标准剂量CT引导相当的诊断准确率,同时显著降低患者辐射剂量。
研究设计与样本
- 单中心、单盲、前瞻性随机对照试验,2016年11月至2017年6月纳入280例患者,随机分入低剂量组或标准剂量组,271例接受干预(低剂量组135例,标准剂量组136例);主要终点为诊断准确率,次要终点为技术成功、辐射剂量及相关并发症。
诊断标准与关键数值
- 低剂量组敏感度91.8%、特异度100%、总诊断准确率94.6%;标准剂量组敏感度89.6%、特异度100%、总诊断准确率92.4%;两组诊断性能无显著差异。
临床应用与阅片要点
- 低剂量CT引导下肺活检可用于诊断肺部病灶,诊断准确率与标准剂量方案相当,且辐射剂量显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the relative diagnostic utility of low- and standard-dose computed tomography (CT)-guided lung biopsy.
METHODS: In this single-center, single-blind, prospective, randomized controlled trial, patients were enrolled between November 2016 and June 2017. Enrolled study participants were randomly selected to undergo either low- or standard-dose CT-guided lung biopsy. Diagnostic accuracy was the primary study endpoint, whereas technical success, radiation dose, and associated complications were secondary study endpoints.
RESULTS: In total, 280 patients underwent study enrollment and randomization, with 271 (low-dose group, 135; standard-dose group, 136) receiving the assigned interventions. Both groups had a 100% technical success rate for CT-guided lung biopsy, and complication rates were similar between groups (p > 0.05). The mean dose-length product (36.0 ± 14.1 mGy cm vs. 361.8 ± 108.0 mGy cm, p < 0.001) and effective dose (0.5 ± 0.2 mSv vs. 5.1 ± 1.5 mSv, p < 0.001) were significantly reduced in the low-dose group participants. Sensitivity, specificity, and overall diagnostic accuracy rates in the low-dose group were 91.8%, 100%, and 94.6%, respectively, whereas in the standard-dose group, the corresponding values were 89.6%, 100%, and 92.4%, respectively. These results indicated that diagnostic performance did not differ significantly between the 2 groups. Using univariate and multivariate analyses, we found larger lesion size (p = 0.038) and procedure-related pneumothorax (p = 0.033) to both be independent predictors of diagnostic failure.
CONCLUSIONS: Our results demonstrate that low-dose CT-guided lung biopsy can yield comparable diagnostic accuracy to standard-dose CT guidance, while significantly reducing the radiation dose delivered to patients.
TRIAL REGISTRATION: ClinicalTrials.gov NCT02971176 KEY POINTS: • Low-dose CT-guided lung biopsy is a safe and simple method for diagnosis of lung lesions. • Low-dose CT-guided lung biopsy can yield comparable diagnostic accuracy to standard-dose CT guidance. • Low-dose CT-guided lung biopsy can achieve a 90% reduction in radiation exposure when compared with standard-dose CT guidance.
引用
- Fu YF, Li GC, Xu QS, et al. Computed tomography-guided lung biopsy: a randomized controlled trial of low-dose versus standard-dose protocol. Eur Radiol. 2019. PMID: 31776740. doi:10.1007/s00330-019-06464-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。